X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (9983) 9983
Newsletter (41) 41
Magazine Article (26) 26
Book Chapter (21) 21
Dissertation (7) 7
Book / eBook (5) 5
Book Review (4) 4
Newspaper Article (4) 4
Conference Proceeding (2) 2
Publication (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (7795) 7795
valproic acid - therapeutic use (5273) 5273
valproic acid (4683) 4683
male (4331) 4331
female (4253) 4253
anticonvulsants - therapeutic use (3071) 3071
adult (2729) 2729
clinical neurology (2329) 2329
animals (2035) 2035
epilepsy - drug therapy (2021) 2021
epilepsy (1974) 1974
adolescent (1806) 1806
middle aged (1782) 1782
valproic acid - adverse effects (1745) 1745
pharmacology & pharmacy (1706) 1706
psychiatry (1705) 1705
child (1687) 1687
neurosciences (1428) 1428
divalproex (1365) 1365
valproic acid - pharmacology (1316) 1316
anticonvulsants - adverse effects (1274) 1274
treatment outcome (1192) 1192
drug therapy, combination (1139) 1139
bipolar disorder - drug therapy (1132) 1132
valproate (1082) 1082
carbamazepine - therapeutic use (1058) 1058
antiepileptic drugs (1054) 1054
carbamazepine (975) 975
aged (942) 942
valproic acid - administration & dosage (938) 938
child, preschool (934) 934
bipolar disorder (884) 884
seizures (884) 884
sodium valproate (858) 858
neurology (816) 816
children (797) 797
anticonvulsants (779) 779
mice (778) 778
analysis (773) 773
rats (756) 756
dose-response relationship, drug (720) 720
drug therapy (700) 700
antimanic agents - therapeutic use (692) 692
electroencephalography (615) 615
lithium (609) 609
lamotrigine (605) 605
valproic acid - blood (600) 600
drug interactions (593) 593
pregnancy (593) 593
anticonvulsants - pharmacology (592) 592
drugs (582) 582
infant (577) 577
pediatrics (571) 571
research (569) 569
double-blind (550) 550
histone deacetylase inhibitors (548) 548
oncology (545) 545
antipsychotic agents - therapeutic use (543) 543
disease models, animal (522) 522
care and treatment (520) 520
seizures - drug therapy (514) 514
health aspects (508) 508
young adult (506) 506
anticonvulsants - administration & dosage (487) 487
cancer (484) 484
phenytoin - therapeutic use (468) 468
retrospective studies (465) 465
therapy (465) 465
apoptosis (456) 456
gene expression (452) 452
phenytoin (448) 448
histone deacetylase (443) 443
medicine & public health (443) 443
risk factors (434) 434
pharmacokinetics (423) 423
biochemistry & molecular biology (413) 413
expression (411) 411
time factors (410) 410
efficacy (407) 407
anticonvulsants - pharmacokinetics (401) 401
brain (396) 396
valproic acid - pharmacokinetics (396) 396
triazines - therapeutic use (391) 391
epilepsy - blood (385) 385
phenobarbital - therapeutic use (374) 374
acid (354) 354
double-blind method (348) 348
anticonvulsants - blood (347) 347
bipolar disorder - psychology (347) 347
toxicology (346) 346
follow-up studies (344) 344
research article (324) 324
histone deacetylase inhibitors - pharmacology (318) 318
in-vitro (317) 317
metabolism (317) 317
proteins (314) 314
cell biology (313) 313
carbamazepine - adverse effects (307) 307
gene-expression (306) 306
patients (305) 305
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (9444) 9444
French (153) 153
Spanish (149) 149
German (141) 141
Russian (98) 98
Japanese (79) 79
Polish (38) 38
Italian (36) 36
Portuguese (30) 30
Chinese (27) 27
Danish (18) 18
Dutch (16) 16
Norwegian (11) 11
Hungarian (9) 9
Turkish (9) 9
Czech (5) 5
Finnish (4) 4
Hebrew (4) 4
Ukrainian (4) 4
Slovak (2) 2
Bulgarian (1) 1
Croatian (1) 1
Korean (1) 1
Serbian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2003, Volume 63, Issue 16, 41
The trigeminal autonomic cephalgias (TACs) are a group of primary headache disorders characterised by unilateral trigeminal distribution pain that occurs in... 
Methysergide, therapeutic use | Headache, treatment | Antiepileptic drugs, therapeutic use | Capsaicin, therapeutic use | Antimigraines, therapeutic use | Research and development | Cluster headache, treatment | Oxygen inhalation therapy | Leuprorelin, therapeutic use | Somatostatin, therapeutic use | Local anaesthetics, therapeutic use | Surgery | Civamide, therapeutic use | Clonidine, therapeutic use | Dihydroergotamine mesylate, therapeutic use | Nimodipine, therapeutic use | Lidocaine, therapeutic use | Calcium channel antagonists, therapeutic use | Methylergometrine, therapeutic use | Olanzapine, therapeutic use | Nerve block | Zolmitriptan, therapeutic use | Dehydroemetine, therapeutic use | Valproic acid, therapeutic use | Migraine, treatment | Baclofen, therapeutic use | Melatonin, therapeutic use | Lithium, therapeutic use | Verapamil, therapeutic use | Ergotamine, therapeutic use | Chlorpromazine, therapeutic use | Serotonin 1D receptor agonists, therapeutic use | Sumatriptan, therapeutic use | Cocaine, therapeutic use | Analgesics, therapeutic use | Pizotifen, therapeutic use | Corticosteroids, therapeutic use | Gabapentin, therapeutic use | Topiramate, therapeutic use | Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | SUNCT SYNDROME | CONJUNCTIVAL INJECTION | PROPHYLACTIC TREATMENT | PHARMACOLOGY & PHARMACY | TOXICOLOGY | UNILATERAL NEURALGIFORM HEADACHE | PLACEBO-CONTROLLED TRIAL | LITHIUM-CARBONATE | BRAIN-STEM ACTIVATION | MIGRAINOUS NEURALGIA | CHRONIC PAROXYSMAL HEMICRANIA | EPISODIC CLUSTER HEADACHE | Analgesics - pharmacology | Analgesics - therapeutic use | Ergot Alkaloids - pharmacology | Oxygen - pharmacology | Drug Administration Schedule | Humans | Sumatriptan - therapeutic use | Trigeminal Neuralgia - diagnosis | Trigeminal Neuralgia - physiopathology | Vascular Headaches - diagnosis | Male | Anesthetics, Local - pharmacology | Oxazolidinones - therapeutic use | Vascular Headaches - physiopathology | Sumatriptan - pharmacology | Oxazolidinones - pharmacology | Trigeminal Neuralgia - drug therapy | Ergot Alkaloids - therapeutic use | Female | Anesthetics, Local - therapeutic use | Tryptamines | Vascular Headaches - drug therapy
Book Review
Lancet neurology, ISSN 1474-4422, 2011, Volume 10, Issue 7, pp. 609 - 617
Journal Article
Journal Article
CNS Drugs, ISSN 1172-7047, 2005, Volume 19, Issue 1, pp. 13 - 25
.... Among dopaminergic agents tested for cocaine pharmacotherapy, disulfiram has decreased cocaine use in a number of studies... 
Ecopipam, therapeutic use | Vasodilators, therapeutic use | Bromocriptine, therapeutic use | Mazindol, therapeutic use | Valproic acid, therapeutic use | Amantadine, therapeutic use | Cocaine abuse, treatment | Baclofen, therapeutic use | Cocaine abuse vaccine TA CD, therapeutic use | Adrogolide, therapeutic use | Research and development | Disulfiram, therapeutic use | Progesterone, therapeutic use | Adrenoceptor antagonists, therapeutic use | Selegiline, therapeutic use | Methylphenidate, therapeutic use | Tiagabine, therapeutic use | Gabapentin, therapeutic use | Topiramate, therapeutic use | Pharmacotherapy | Neurology | Neurosciences | Medicine & Public Health | Psychiatry | Psychopharmacology | INDUCED REINSTATEMENT | PSYCHIATRY | SMOKED COCAINE | CLINICAL NEUROLOGY | VENTRAL TEGMENTAL AREA | CEREBRAL PERFUSION | MESSENGER-RNA | SUBJECTIVE RESPONSE | MEDIAL PREFRONTAL CORTEX | PHARMACOLOGY & PHARMACY | PLACEBO-CONTROLLED TRIAL | DOPAMINE-RECEPTORS | PROGESTERONE TREATMENT | Immunotherapy - methods | Vasodilator Agents - therapeutic use | gamma-Aminobutyric Acid - metabolism | Brain - physiopathology | Humans | Cocaine-Related Disorders - therapy | Cocaine-Related Disorders - epidemiology | Dopamine Agents - therapeutic use | Disulfiram - therapeutic use | Brain - metabolism | Adrenergic Agents - therapeutic use | Animals | GABA Agents - therapeutic use | Dopamine - metabolism | Epinephrine - metabolism
Journal Article
Epilepsia (Copenhagen), ISSN 0013-9580, 2017, Volume 58, Issue 10, pp. 1734 - 1741
Summary Objective Mesial temporal lobe epilepsy with hippocampal sclerosis (MTLE‐HS) is a common epilepsy syndrome that is often poorly controlled by... 
Drug response | Efficacy | Adverse drug reactions | Retention | Seizure freedom | CONTROLLED-TRIAL | REFRACTORY EPILEPSY | PROGNOSIS | LOCALIZATION-RELATED EPILEPSY | TOPIRAMATE | RETENTION RATES | NATURAL-HISTORY | CLINICAL NEUROLOGY | THERAPY | LAMOTRIGINE | RESISTANT EPILEPSY | Pregabalin - therapeutic use | Triazines - therapeutic use | Humans | Middle Aged | Epilepsy, Temporal Lobe - drug therapy | Epilepsy, Temporal Lobe - physiopathology | Male | Sclerosis | Young Adult | Amines - therapeutic use | Vision Disorders - chemically induced | Adult | Female | Valproic Acid - therapeutic use | Retrospective Studies | gamma-Aminobutyric Acid - therapeutic use | Epilepsy, Temporal Lobe - pathology | Databases, Factual | Diplopia - chemically induced | Cyclohexanecarboxylic Acids - therapeutic use | Carbamazepine - analogs & derivatives | Vertigo - chemically induced | Dizziness - chemically induced | Anticonvulsants - therapeutic use | Carbamazepine - therapeutic use | Treatment Outcome | Hippocampus - pathology | Lethargy - chemically induced | Fructose - therapeutic use | Fructose - analogs & derivatives | Vigabatrin - therapeutic use | Adolescent | Aged | Ataxia - chemically induced | Benzodiazepines - therapeutic use | Medical research | Care and treatment | Anticonvulsants | Medicine, Experimental | Temporal lobe epilepsy | Seizures (Medicine) | Comparative analysis | Topiramate | Temporal lobe | Gabapentin | Epilepsy | Clinical trials | Valproic acid | Antiepileptic agents | Carbamazepine | Vertigo | Oxcarbazepine | Convulsions & seizures | Drowsiness | Ataxia | Hippocampus | Lamotrigine
Journal Article
Circulation (New York, N.Y.), ISSN 0009-7322, 07/2012, Volume 126, Issue 4, pp. 455 - 467
.... Immunohistochemistry localized increased expression to remodeled vessels in the lung. Both valproic acid, a class I HDAC inhibitor, and suberoylanilide hydroxamic acid (vorinostat... 
genetic | epigenesis | vorinostat | histone deacetylation | pulmonary | valproic acid | hypertension | TARGET | CELLS | APOPTOSIS | CARDIAC & CARDIOVASCULAR SYSTEMS | ACETYLATION | hypertension, pulmonary | epigenesis, genetic | PROLIFERATION | EMERGENCE | ARTERIAL-HYPERTENSION | PROSTATE-CANCER | IN-VIVO | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | EXPRESSION | Muscle, Smooth, Vascular - metabolism | Humans | Male | Valproic Acid - pharmacology | Pulmonary Artery - metabolism | Histone Deacetylase 1 - antagonists & inhibitors | Valproic Acid - therapeutic use | Hypertension, Pulmonary - drug therapy | Lung - metabolism | Hydroxamic Acids - pharmacology | Disease Models, Animal | Muscle, Smooth, Vascular - drug effects | Lung - pathology | Cells, Cultured | Rats | Histone Deacetylases - metabolism | Hypertension, Pulmonary - metabolism | Hypoxia - complications | Platelet-Derived Growth Factor - pharmacology | Pulmonary Artery - drug effects | Rats, Sprague-Dawley | Muscle, Smooth, Vascular - pathology | Animals | Lung - drug effects | Histone Deacetylase Inhibitors - pharmacology | Histone Deacetylases - drug effects | Hydroxamic Acids - therapeutic use | Cell Proliferation - drug effects | Histone Deacetylase Inhibitors - therapeutic use | Hypertension, Pulmonary - etiology | Pulmonary Artery - pathology | Histone Deacetylase 1 - metabolism | Cell proliferation | Divalproex | Care and treatment | Usage | Enzyme inhibitors | Physiological aspects | Research | Valproic acid | Health aspects | Pulmonary hypertension
Journal Article
Journal Article
Clinical cancer research, ISSN 1557-3265, 2009, Volume 15, Issue 12, pp. 3958 - 3969
Journal Article